-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Globally, strokes caused by spontaneous intracerebral hemorrhage (ICH) account for about a quarter of all strokes.
Globally, strokes caused by spontaneous intracerebral hemorrhage (ICH) account for about a quarter of all strokes.
Pixabay.
Pixabay.
In 2019, the results of a study called RESTART showed that the prognosis of ICH is related to the use of antithrombotic drugs.
Based on these questions, some researchers have analyzed these risks in population-based studies and compared them with the risks in RESTART, which evaluates antiplatelet therapy after cerebral hemorrhage.
The researchers aggregated data from two prospective, population-based initial cohort studies ( OXVASC and LATCH cohort studies ) from Oxfordshire, England , to quantify recurrent cerebral hemorrhage, ischemic stroke or any serious vascular events (non-fatal stroke, The absolute and relative risks of non-fatal myocardial infarction or vascular death) were stratified according to the location of cerebral hemorrhage (large lobe vs non-large lobe) and whether it was combined with atrial fibrillation (AF).
The researchers aggregated data from two prospective, population-based initial cohort studies ( OXVASC and LATCH cohort studies ) from Oxfordshire, England , to quantify recurrent cerebral hemorrhage, ischemic stroke or any serious vascular events (non-fatal stroke, The absolute and relative risks of non-fatal myocardial infarction or vascular death) were stratified according to the location of cerebral hemorrhage (large lobe vs non-large lobe) and whether it was combined with atrial fibrillation (AF).
The results showed that among the 674 participants, 46 cases of recurrent ICH (event rate 3.
Use all follow-up data to compare RESTART with OXVASC and LATCH combined cohort
Use all follow-up data to compare RESTART with OXVASC and LATCH combined cohort Use all follow-up data to compare RESTART with OXVASC and LATCH combined cohortThese studies based on real populations provide some support for the external effectiveness of RESTART.
These studies based on real populations provide some support for the external effectiveness of RESTART.
These findings have implications for clinical practice and future research.
References: Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies Linxin Li, DPhil * Michael TC Poon, MSc * Neshika E Samarasekera, PhD Luke A Perry, MBBS Tom J Moullaali, MRCP Mark A Rodrigues, PhD et al.
Show all authors Show footnotes Open AccessPublished:June, 2021 DOI:https://doi.
org/10.
1016/S1474-4422(21)00075-2 References:Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies Linxin Li, DPhil * Michael TC Poon, MSc * Neshika E Samarasekera, PhD Luke A Perry, MBBS Tom J Moullaali, MRCP Mark A Rodrigues, PhD et al.
Show all authors Show footnotes Open AccessPublished:June, 2021DOI: https://doi.
org/10.
1016/S1474-4422(21)00075-2 DOI: https://doi.
org/10.
1016/S1474-4422(21)00075-2 Leave a message here
